- Home
- NKTX vs FCAP Comparison
NKTX vs FCAP Comparison
Compare NKTX & FCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- FCAP
- Stock Information
- Founded
- NKTX 2015
- FCAP 1891
- Country
- NKTX United States
- FCAP United States
- Employees
- NKTX N/A
- FCAP N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- FCAP Savings Institutions
- Sector
- NKTX Health Care
- FCAP Finance
- Exchange
- NKTX Nasdaq
- FCAP Nasdaq
- Market Cap
- NKTX 123.5M
- FCAP 161.2M
- IPO Year
- NKTX 2020
- FCAP 1999
- Fundamental
- Price
- NKTX $1.74
- FCAP $49.14
- Analyst Decision
- NKTX Strong Buy
- FCAP
- Analyst Count
- NKTX 6
- FCAP 0
- Target Price
- NKTX $14.80
- FCAP N/A
- AVG Volume (30 Days)
- NKTX 422.6K
- FCAP 10.6K
- Earning Date
- NKTX 05-14-2025
- FCAP 07-25-2025
- Dividend Yield
- NKTX N/A
- FCAP 2.36%
- EPS Growth
- NKTX N/A
- FCAP 2.61
- EPS
- NKTX N/A
- FCAP 3.65
- Revenue
- NKTX N/A
- FCAP $42,869,000.00
- Revenue This Year
- NKTX N/A
- FCAP N/A
- Revenue Next Year
- NKTX N/A
- FCAP N/A
- P/E Ratio
- NKTX N/A
- FCAP $13.45
- Revenue Growth
- NKTX N/A
- FCAP 6.35
- 52 Week Low
- NKTX $1.31
- FCAP $27.10
- 52 Week High
- NKTX $8.23
- FCAP $53.85
- Technical
- Relative Strength Index (RSI)
- NKTX 45.11
- FCAP 57.66
- Support Level
- NKTX $1.70
- FCAP $48.50
- Resistance Level
- NKTX $1.82
- FCAP $50.50
- Average True Range (ATR)
- NKTX 0.10
- FCAP 1.11
- MACD
- NKTX -0.01
- FCAP -0.21
- Stochastic Oscillator
- NKTX 18.82
- FCAP 54.39
About NKTX Nkarta Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
About FCAP First Capital Inc.
First Capital Inc is the financial holding company of First Harrison Bank. Through its subsidiary, it operates as a federally-chartered savings bank that provides banking services to individuals and business customers across locations in America. The bank offers various loans which include residential loans, construction loans, commercial real estate loans and commercial business loans. It also provides consumer loans such as home equity and second mortgage loans, and automobile and truck loans.